Hans-Peter Hammes
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research 5
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 6
- Glaucoma and retinal disorders 3
- Neurology top 2%
- Immunology and Allergy top 5%
-
- Angiogenesis and VEGF in Cancer 4
- Retinal Development and Disorders 3
-
- Retinal Imaging and Analysis 3
-
- Alcohol Consumption and Health Effects 2
-
- Lipid metabolism and disorders 2
- Co-authors
- Michael BrownleeJihong LinYuxi FengUrban DeutschOliver RennerFrederick PfisterChrister BetsholtzMoshe Shani
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hans-Peter Hammes
19 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Clinical Biochemistry 639
- Ophthalmology 733
- Neurology 306
- Endocrinology, Diabetes and Metabolism 364
- Immunology and Allergy 124
Countries citing papers authored by Hans-Peter Hammes
This map shows the geographic impact of Hans-Peter Hammes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Peter Hammes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Peter Hammes more than expected).
Fields of papers citing papers by Hans-Peter Hammes
This network shows the impact of papers produced by Hans-Peter Hammes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Peter Hammes. The network helps show where Hans-Peter Hammes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans-Peter Hammes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2018 | 29 | |
| 4 | 2018 | 7 | |
| 5 | 2018 | 36 | |
| 6 | 2017 | 35 | |
| 7 | 2014 | 22 | |
| 8 | 2013 | 44 | |
| 9 | 2010 | 284 | |
| 10 | 2009 | 64 | |
| 11 | 2009 | 153 | |
| 12 | 2007 | 191 | |
| 13 | 2006 | 130 | |
| 14 | 2006 | 10 | |
| 15 | 2004 | 261 | |
| 16 | 2003 | 67 | |
| 17 | Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathybreakdown → | 2003 | 603 |
| 18 | 2003 | 150 | |
| 19 | Pericytes and the Pathogenesis of Diabetic Retinopathybreakdown → | 2002 | 537 |
About Hans-Peter Hammes
Hans-Peter Hammes is a scholar working on Ophthalmology, Clinical Biochemistry and Aging, having authored 19 papers that have together received 2.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (6 papers), Advanced Glycation End Products research (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Glaucoma and retinal disorders (3 papers), Retinal Development and Disorders (3 papers), Retinal Imaging and Analysis (3 papers), Alcohol Consumption and Health Effects (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Clinical Biochemistry (639 citations), Ophthalmology (733 citations) and Neurology (306 citations). Hans-Peter Hammes has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Brownlee, Jihong Lin, Yuxi Feng, Urban Deutsch, Oliver Renner, Frederick Pfister, Christer Betsholtz, Michael Brownlee, Moshe Shani and Takeshi Matsumura. Their work appears in journals such as Diabetes, Journal of Biological Chemistry, Scientific Reports, Nature Medicine and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.